摘要
目的评价头孢丙烯治疗上呼吸道细菌性感染的有效性和安全性。方法118例轻、中度上呼吸道细菌性感染患者,随机分为2组,头孢丙烯组60例,给予头孢丙烯500mg,po,qd;头孢克洛组58例,给予头孢克洛500mg,po,tid。疗程均为7～14d。结果头孢丙烯组与头孢克洛组临床有效率分别为9333%与9138%,细菌清除率分别为9148%与8695%。2组均无明显不良反应。结论采用头孢丙烯治疗上呼吸道细菌性感染安全、有效。
Objective: To evaluate the efficacy and safety of cefprozil in the treatment of bacterial infection of upper respiratory tract. Methods: 118 patients with mild to moderate bacterial infection of upper respiratory tract were divided into two groups in random. 60 patients were treated with cefprozil, the single dose was 500mg in once a day orally. 58 patients were treated with cefaclor, the divided dose was 500mg in three times a day. Both of the two groups were treated for 7-14 days. Results: The total clinical effective rates of cefprozil group and cefaclor group were 93.33% and 91.38% respectively. The bacterial clearance rates were 91.48% and 86.95% respectively. Two groups were without obvious adverse reactions. Conclusions: Cefprozil appeared to be a highly effective and safe agent
出处
《中国民康医学》
2004年第8期463-464,共2页
Medical Journal of Chinese People’s Health
关键词
头孢丙烯
头孢克洛
呼吸道感染
Cefprozil
Cefaclor
Respiratory tract infections
